MDX Medx Health Corp

MedX Shares May Be Trading Within 2-3 days After Exchange Review MISSISSAUGA, ON, May 9, 2012 /CNW/ - MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser light therapy and light imaging systems, today announced the company has been notified by the Ontario Securities Commission that the Cease Trade Order issued May 7, 2012 has been lifted, since the Company has now filed all financial documents required; however, reinstatement to trading can occur only after the Exchange has concluded its reinstatement review to ensure the Company has satisfactorily complied with Exchange requirements.  The reinstatement review process usually takes a minimum of two (2) days, and would mean the shares could possibly be trading as early as next week. About MedX Health Corp. MedX is a twelve (12) year old Canadian company, headquartered in Mississauga, Ontario (Toronto), and is a global leader in the design, manufacturing and distribution of quality low level laser and light therapy technologies for use in numerous medical settings, including rehab/chiropractic, dental, wound care, and veterinary medicine, providing patients with drug free and non-invasive treatment of tissue damage and pain. MedX laser and light products are FDA approved, Health Canada cleared, and CE Mark approved for use in North America as well as the European Union. MedX Health acquired the worldwide assets of MoleMate, for early detection of skin cancer, in June, 2011.  For a complete profile of MoleMate and the core technologies visit www.simsys-molemate.com. This press release does not constitute an offer of any securities for sale.  This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation.  These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements.  All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. MedX Health Corp. CONTACT: Contacts:Investors:Steve GuillenPresident and Chief Executive OfficerMedX Health Corp. investor@medxhealth.comPhone: (905) 670-4428

Copyright